Discovery chemistry from hit identification to scale-up
In vitro and in vivo biology solutions for drug discovery.
ADME, PK, bioanalysis, and toxicology services
Drug substance and drug product capabilities
BioDuro Discovery Platforms
A global CRDMO, built to be your trusted strategic partner.
Meet the scientists, leaders, and innovators who shaped BioDuro.
Webinars
Explore evolving FDA and EU regulatory expectations for INDs, CMC, nonclinical development, and market authorization strategies.
Discover integrated DMPK, ADME, and bioanalytical strategies to accelerate preclinical screening and candidate selection for large-molecule therapeutics.
Explore fragment-based drug discovery using SPR, computational expansion, and medicinal chemistry to accelerate lead discovery.
Discover solid form optimization strategies, including polymorphs, salts, and cocrystals, to improve drug properties and accelerate development.
Explore cyclic peptide discovery strategies to target challenging proteins, improve oral bioavailability, and accelerate therapeutic development.
Discover integrated chemistry, biology, and DMPK strategies to accelerate ADC discovery and support informed preclinical decisions.
Explore practical synthesis and in vitro profiling strategies for PROTACs, RIPTACs, and molecular glues in early drug discovery.
Learn how peptide DNA-encoded libraries improve peptide discovery with diverse chemistries, advanced screening, and AI-powered insights.
Explore strategies to improve peptide metabolic stability through advanced analytics, rational design, and in vitro metabolism studies.
Discover early formulation and DMPK strategies to overcome poor solubility, improve bioavailability, and accelerate clinical development.
Learn how translational DIO rodent models accelerate obesity drug discovery through optimized study design and predictive preclinical data.
Discover integrated DMPK and bioanalytical strategies to optimize ADC ADME, bioanalysis, and regulatory success from discovery to development.
